The report “Asia Pacific Biotechnology Market (2008-2012)” provides an exhaustive view of the biotechnology markets in the Asia-Pacific region The report “Asia Pacific Biotechnology Market (2008-2012)” provides an exhaustive view of the biotechnology markets in the Asia-Pacific region (Japan, China, Australia, South Korea, India, Taiwan, New Zealand and Singapore). It also provides a detailed account of the major factors driving growth in the biotechnology industry of the region and enabling it to become a dominant force in the future.
As per our research, countries in the Asia-Pacific region were late starters in the biotechnology market. However, the industry is growing much faster than the industries in North America and Europe, primarily due to low costs, strong government support, large talent pool and biodiversity. In future both India and China are expected to emerge as leading players in the global biotechnology market.
Information on the market size, structure, segmentation, growth, future forecasts, success and risk factors and evolving trends in technology development are thoroughly analyzed in this report.
The report also covers the fact that the biotechnology markets in the Asia-Pacific region have huge differences from one another in terms of infrastructure, funding, talent pool, growth, size and potential as an outsourcing destination. Thus, it provides valuable information to pharmaceutical & biotechnology companies and investors looking to enter these markets and help them to devise strategies in accordance to the individual markets.
Key Findings
– Growing at an estimated CAGR of 15.9% between 2005 and 2007, the value of Asia-Pacific Biotechnology market in 2007 was more than US$ 41 Billion.
– Japan, China, and Australia are the three largest biotechnology markets in the Asia-Pacific region, with combined market share of around 79% in 2007. The medical biotechnology sector presently accounts for the highest share in the overall market.
– Japan remains the largest biotech market in the region; therefore, the country represents a more mature market as compared to other neighboring markets.
– China and India, with low costs and big talent pool, are likely to emerge as the most potential biotech research and manufacturing outsourcing destinations in the future.
– Asia-Pacific is expected to become a major destination for stem cell research and biogeneric manufacturing.
Key Issues and Facts
The research report addresses the issues and facts critical to success in the emerging biotechnology industry in Asia-Pacific:
– What are the market trends in the Asia-Pacific Biotechnology industry?
– An insight into the biotechnology industries of Japan, China, India, South Korea, Australia, Taiwan, New Zealand and Singapore.
– An overview of Bioclusters in the Asia-Pacific Biotechnology industry.
– Key sectors in the Asia-Pacific Biotechnology industry.
– Course of market growth for the next 5 years.
– Opportunities that can be leveraged by the Asia-Pacific Biotechnology industry.
– Forces that are driving the biotechnology industry in the Asia-Pacific region.
– Challenges faced by the Asia-Pacific Biotechnology industry.
Research Methodology
Information Sources
Information has been sourced from various authentic and reliable sources like books, newspapers, trade journals & white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.
Analysis Methods
The analysis methods comprise of Ratio Analysis, Historical Trend Analysis, Linear Regression Analysis (using software tools), Judgmental Forecasting, and Cause and Effect Analysis.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM138.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today’s globally competitive environment.
